Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2

Biochemical and Biophysical Research Communications

Volumn 417, Issue 2, 2012, Pages 790-793

  Kato, Kohei ^a   Fukui, Rie ^a   Okabe, Kyoko ^a   Tanabe, Eriko ^a   Kitayoshi, Misaho ^a   Fukushima, Nobuyuki ^a   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

B103; LPA receptor; Lysophosphatidic acid; Matrix metalloproteinase

Indexed keywords

GELATINASE A; GELATINASE B; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GENE MUTATION; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ANIMALS; CELL LINE, TUMOR; ENZYME ACTIVATION; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEUROBLASTOMA; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID;

RATTUS;

EID: 84855834596     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.036     Document Type: Article

References (24)

1. Lin M.-E., Herr D.R., Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010, 91:130-138.
2. Aoki J., Inoue A., Okudaira S. Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta 2008, 1781:513-518.
3. Ishii I., Fukushima N., Ye X., Chun J. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 2004, 73:321-354.
4. Shida D., Kitayama J., Yanaguchi H., Okaji Y., Tsuno N.H., Watanabe T., Takuwa Y., Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003, 63:1706-1711.
5. Furui T., LaPushin R., Mao M., Khan H., Watt S.R., Watt M.A.V. Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin. Cancer Res. 1999, 5:4308-4318.
6. Yamada T., Furukawa M., Hotta M., Yamasaki A., Honoki K., Fukushima N., Tsujiuchi T. Mutations of lysophosphatidic acid receptor-1 gene during progression of lung tumors in rats. Biochem. Biophys. Res. Commun. 2009, 378:424-427.
7. Obo Y., Yamada T., Furukawa M., Hotta M., Honoki K., Fukushima N., Tsujiuchi T. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors. Mutat. Res. 2009, 660:47-50.
8. Tsujiuchi T., Shimizu K., Onishi M., Sugata E., Fujii H., Mori T., Honoki K., Fukushima N. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem. Biophys. Res. Commun. 2006, 349:1151-1155.
9. Wakabayashi N., Tsujino M., Tajiri M., Taki M., Koshino A., Ikeda H., Fukushima N., Tsujiuchi T. No mutations of lysophosphatidic acid receptor genes in lung adenocarcinomas induced by N-nitrosobis-(2-hydroxypropyl)amine in rats. J. Toxicol. Pathol. 2010, 3:63-66.
10. A1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl. Acad. Sci. USA 1998, 95:6151-6156.
11. A3/EDG-7 in neural cell lines using a retrovirus expression system. Mol. Pharmacol. 2000, 58:895-902.
12. 9 /GPR23 mediates Rho-dependent morphological changes in a rat neural cell line. J. Biol. Chem. 2007, 282:5814-5824.
13. Sayas C.L., Ariaens A., Ponsionen B., Moolenaar W.H. GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction. Mol. Biol. Cell 2006, 17:1834-1844.
14. M. Hayashi, K. Okabe, K. Kato, M. Okumura, R. Fukui, N. Fukushima, T. Tsujiuchi, Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett. (2011) doi: doi:10.1016/j.canlet.2011.10.030.
15. Shano S., Hatanaka K., Ninose S., Moriyama R., Tsujiuchi T., Fukushima N. A Lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim. Biophys. Acta 2008, 1783:748-759.
16. Okabe K., Hayashi M., Yamawaki Y., Teranishi M., Honoki K., Mori T., Fukushima N., Tsujiuchi T. Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells. Mol. Carcinog. 2011, 50:635-642.
17. Okabe K., Kato K., Teranishi M., Okumura M., Fukui R., Mori T., Fukushima N., Tsujiuchi T. Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells. Cancer Lett. 2011, 309:236-242.
18. Ito A., Nakajima S., Sasaguri Y., Nagase H., Mori Y. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br. J. Cancer 1995, 71:1039-1045.
19. K. Okabe, M. Hayashi, K. Kato, M. Okumura, R. Fukui, K. Honoki, N. Fukushima, T. Tsujiuchi, Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells, Mol. Carcinog. (2011) in press, doi:10.1002/mc.21851.
20. Chen P., Parks W.C. Role of matrix metalloproteinases in epithelial migration. J. Cell. Biochem. 2009, 108:1233-1243.
21. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
22. Park S.Y., Jeong K.J., Panupinthu N., Yu S., Lee J., Han J.W., Kim J.M., Lee J-S., Kang J., Park C.G., Mills G.B., Lee H.Y. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene 2011, 30:1351-1359.
23. q/11-selective inhibitor. J. Biol. Chem. 2004, 279:47438-47445.
24. Zaslavsky A., Singh L.S., Tan H., Ding H., Liang Z., Xu Y. Homo- and hetero-demerization of LPA/SIP receptors, OGR1 and GPR4. Biochim. Biophys. Acta 2006, 1761:1200-1212.